Editor’s Note: The home page of the BioNJ website provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in the News section are encouraged to send their news releases to BioNJ via email.
September 15
Over 1000 Patients Have Benefited from STENTYS Self-Apposing Technology
September 14
Celgene Corporation to Present at Three Upcoming Investor Conferences
Merck to Present at Bank of America Merrill Lynch Global Healthcare Conference
September 13
Merck and BGI Establish Strategic Collaboration focused on Biomarkers and Genomic Technologies
LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects
Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
September 12
Costs, Mortality Skyrocket Following Infection in Cardiac Device Recipients
Feds Award Elusys $69 Million to Develop Anthrax Drug
Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
September 8
Unigene to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12, 2011
September 7
Edge Therapeutics Appoints Dr. Sol J. Barer to Board of Directors
CorMedix to Present at the Rodman & Renshaw Annual Global Investment Conference
Unigene Appoints Industry Veteran Theron (Ted) Odlaug as New Independent Director to Board
September 6
CorMedix Announces Amended Agreement for CRMD001 (a proprietary formulation of deferiprone)
Senesco to Present at 13th Annual Rodman & Renshaw Healthcare Conference
NPS Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
September 1
August 31
Celgene Corporation to Present at Three Upcoming Investor Conferences
August 30
Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
Unigene Successfully Defends Its Robust Intellectual Property Portfolio
August 28
August 25
Columbia Laboratories to Present at Upcoming Equity Conferences in September
SyntheMed, Inc. Announces Stockholder Approval of Planned Merger With Pathfinder, LLC
August 24
Immunomedics Announces Fiscal 2011 Results
Senesco Finalizes Agreement with Mayo Clinic to Study SNS01-T in Multiple Myeloma
August 23
August 22
Catalent Pharma Solutions Reaches Agreement to Acquire Aptuit LLC’s Clinical Trial Supplies Business
August 18
Celgene Announces Additional $2 Billion Share Repurchase Authorization
August 16
Derma Sciences Reports Second Quarter Operating Results
August 15
Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESC Highlights
August 12
Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
NovaDel Reports Financial Results for Second Quarter 2011
CorMedix Announces Appointment of Steven W. Lefkowitz to Board of Directors
August 11
Genta Incorporated Reports Second Quarter 2011 Financial Results and Recent Corporate Highlights
Advaxis Completes Pre-IND Meeting for ADXS-PSA
Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
August 10
Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 16
August 9
Immunomedics to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
CorMedix Reports Second Quarter 2011 Results
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results
Pharmasset Announces Two-for-One Forward Stock Split
August 8
Antares Pharma Reports Second Quarter 2011 Financial and Operating Results
Top-10 Pharmaceutical Company Renews Support Services Contract with Cegedim Relationship Management
Senesco Technologies Selects Criterium to Manage Multiple Myeloma Study
Tobira Therapeutics Announces Key Management Team Additions
Unigene Reports Second Quarter 2011 Financial Results
Amicus Therapeutics Announces Second Quarter 2011 Financial Results and Multiple Upcoming Milestones
August 7
Pharmasset to Present at Canaccord Genuity Growth Conference
August 4
Unigene to Present at the 2011 Canaccord Genuity Growth Conference on August 9, 2011
Celgene Corporation to Present at 2011 Canaccord Genuity Growth Conference
Columbia Laboratories Reports Second Quarter 2011 Financial Results
Aegerion Pharmaceuticals to Present at the 2011 Canaccord Genuity Growth Conference
Amicus Therapeutics to Present at Canaccord Genuity Growth Conference on Wednesday, August 10, 2011
Antares Pharma Announces Positive study Results with VIBEX™ MTX in Rheumatoid Arthritis Patients
Enzon Reports 2nd Quarter 2011 Results
Lux Biosciences Receives Complete Response Letter from FDA for Luveniq™
August 3
NPS Pharmaceuticals to Present at Canaccord Genuity Growth Conference
Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-536 Program
August 2
NPS Pharmaceuticals Announces New Calcilytics Agreement with GSK
Quintiles, Kadrige Open E-Solutions Operation in the US
Derma Sciences Launches Wound Treatment Video Series on eLearning Portal
Unigene to Announce Second Quarter 2011 Financial Results on August 8, 2011
Antares Pharma to Host Second Quarter 2011 Earnings Call
July 29
Merck Announces Second Quarter 2011 Financial Results
U.S. FDA Provides Response to Perampanel New Drug Application
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
July 28
Roka Bioscience Completes $20 Million Series C Financing
Soligenix Announces Expansion of Partnership with Sigma-Tau Pharmaceuticals for orBec® in Europe
Lexicon’s IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
Celgene Reports Record Second Quarter 2011 Operating and Financial Results
The Medicines Company Appoints Glenn P. Sblendorio to Board of Directors
July 27
Aegerion Pharmaceuticals Expands Commercial Leadership With Rare Disease Experience
Aegerion Pharmaceuticals Announces Second-Quarter 2011 Financial Results
Lexicon’s IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
The Medicines Company Reports Second Quarter and First Half 2011 Results
July 26
NPS Pharmaceuticals to Report Second Quarter 2011 Financial Results
TKL Research Continues to Strengthen Corporate Excellence
Merck Announces Fourth Quarter 2011 Dividend
NICE Endorses Bivalirudin for Heart Attack Patients
July 25
MedNest Incorporates and Launches PharmaNest
Decision Resources Group Acquires PharmaStrat
Advaxis Revises Protocol for CIN Study
July 22
Aegerion Pharmaceuticals Appoints Dr. Mark Sumeray as Chief Medical Officer
July 21
Merck and Simcere Sign Agreement to Establish Pioneering China Joint Venture
Aegerion Pharmaceuticals Announces Appointment of Paul G. Thomas to Its Board of Directors
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
July 20
Labor Puts Focus on Manufacturing, Health Care, Others in Building Talent Networks
July 19
Aegerion Pharmaceuticals to Announce Second-Quarter 2011 Financial Results on Wednesday, July 27
FDA Advisory Committee Makes Recommendation on Investigational Compound Dapagliflozin